• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

辐射可调节肽库,增强I类主要组织相容性复合体(MHC)的表达,并诱导成功的抗肿瘤免疫疗法。

Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy.

作者信息

Reits Eric A, Hodge James W, Herberts Carla A, Groothuis Tom A, Chakraborty Mala, Wansley Elizabeth K, Camphausen Kevin, Luiten Rosalie M, de Ru Arnold H, Neijssen Joost, Griekspoor Alexander, Mesman Elly, Verreck Frank A, Spits Hergen, Schlom Jeffrey, van Veelen Peter, Neefjes Jacques J

机构信息

Division of Tumor Biology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.

出版信息

J Exp Med. 2006 May 15;203(5):1259-71. doi: 10.1084/jem.20052494. Epub 2006 Apr 24.

DOI:10.1084/jem.20052494
PMID:16636135
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3212727/
Abstract

Radiotherapy is one of the most successful cancer therapies. Here the effect of irradiation on antigen presentation by MHC class I molecules was studied. Cell surface expression of MHC class I molecules was increased for many days in a radiation dose-dependent manner as a consequence of three responses. Initially, enhanced degradation of existing proteins occurred which resulted in an increased intracellular peptide pool. Subsequently, enhanced translation due to activation of the mammalian target of rapamycin pathway resulted in increased peptide production, antigen presentation, as well as cytotoxic T lymphocyte recognition of irradiated cells. In addition, novel proteins were made in response to gamma-irradiation, resulting in new peptides presented by MHC class I molecules, which were recognized by cytotoxic T cells. We show that immunotherapy is successful in eradicating a murine colon adenocarcinoma only when preceded by radiotherapy of the tumor tissue. Our findings indicate that directed radiotherapy can improve the efficacy of tumor immunotherapy.

摘要

放射疗法是最成功的癌症治疗方法之一。在此,研究了辐射对MHC I类分子抗原呈递的影响。由于三种反应,MHC I类分子的细胞表面表达以辐射剂量依赖的方式增加了许多天。最初,现有蛋白质的降解增强,导致细胞内肽库增加。随后,由于雷帕霉素哺乳动物靶点途径的激活,翻译增强,导致肽产生增加、抗原呈递以及细胞毒性T淋巴细胞对受辐照细胞的识别。此外,γ辐射会产生新的蛋白质,导致MHC I类分子呈递新的肽,这些肽被细胞毒性T细胞识别。我们表明,只有在肿瘤组织进行放射治疗之后,免疫疗法才能成功根除小鼠结肠腺癌。我们的研究结果表明,定向放射疗法可以提高肿瘤免疫疗法的疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/558e/3212727/5eb10116f1b4/jem2031259f06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/558e/3212727/b3b324c3e84b/jem2031259f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/558e/3212727/ca765ec23c56/jem2031259f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/558e/3212727/437ea3c5e6bd/jem2031259f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/558e/3212727/44b68293d019/jem2031259f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/558e/3212727/440af3ddc8b1/jem2031259f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/558e/3212727/5eb10116f1b4/jem2031259f06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/558e/3212727/b3b324c3e84b/jem2031259f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/558e/3212727/ca765ec23c56/jem2031259f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/558e/3212727/437ea3c5e6bd/jem2031259f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/558e/3212727/44b68293d019/jem2031259f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/558e/3212727/440af3ddc8b1/jem2031259f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/558e/3212727/5eb10116f1b4/jem2031259f06.jpg

相似文献

1
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy.辐射可调节肽库,增强I类主要组织相容性复合体(MHC)的表达,并诱导成功的抗肿瘤免疫疗法。
J Exp Med. 2006 May 15;203(5):1259-71. doi: 10.1084/jem.20052494. Epub 2006 Apr 24.
2
Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.在一种新型的、转人癌胚抗原和HLA - A2基因的小鼠模型中,采用抗独特型疫苗和癌胚抗原CTL肽联合治疗已形成的肿瘤。
Cancer Res. 2007 Mar 15;67(6):2881-92. doi: 10.1158/0008-5472.CAN-06-3045.
3
Two proliferation-related proteins, TYMS and PGK1, could be new cytotoxic T lymphocyte-directed tumor-associated antigens of HLA-A2+ colon cancer.两种与增殖相关的蛋白,胸苷酸合成酶(TYMS)和磷酸甘油酸激酶1(PGK1),可能是HLA - A2 +结肠癌新的细胞毒性T淋巴细胞导向的肿瘤相关抗原。
Clin Cancer Res. 2004 Sep 1;10(17):5828-36. doi: 10.1158/1078-0432.CCR-04-0350.
4
T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein.T细胞对源自人甲胎蛋白的HLA-A*0201限制性肽段的反应。
J Immunol. 2001 Apr 15;166(8):5300-8. doi: 10.4049/jimmunol.166.8.5300.
5
Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cells.抑制丝氨酸肽酶活性可增强结肠癌细胞中survivin衍生的HLA - A2呈递的CTL表位的产生。
Scand J Immunol. 2008 Dec;68(6):579-88. doi: 10.1111/j.1365-3083.2008.02175.x. Epub 2008 Oct 22.
6
A unique gene having homology with the kinesin family member 18A encodes a tumour-associated antigen recognised by cytotoxic T lymphocytes from HLA-A2+ colon cancer patients.一种与驱动蛋白家族成员18A具有同源性的独特基因编码一种肿瘤相关抗原,该抗原可被来自HLA - A2 +结肠癌患者的细胞毒性T淋巴细胞识别。
Eur J Cancer. 2005 Jun;41(9):1323-30. doi: 10.1016/j.ejca.2005.02.025.
7
Identification of cyclophilin B-derived peptides capable of inducing histocompatibility leukocyte antigen-A2-restricted and tumor-specific cytotoxic T lymphocytes.能够诱导组织相容性白细胞抗原-A2限制的肿瘤特异性细胞毒性T淋巴细胞的亲环素B衍生肽的鉴定。
Jpn J Cancer Res. 2001 Jul;92(7):762-7. doi: 10.1111/j.1349-7006.2001.tb01159.x.
8
Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.肿瘤逃避免疫识别:HLA - A2黑色素瘤细胞表面表达缺失与6号染色体短臂的复杂重排相关。
Clin Cancer Res. 1996 Apr;2(4):641-52.
9
Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-envelope protein to human cytotoxic T lymphocytes.人类免疫缺陷病毒包膜蛋白中一个具有广泛结合性的V3环肽通过HLA - A2.1呈递给人细胞毒性T淋巴细胞的分子分析
Int Immunol. 1996 May;8(5):641-9. doi: 10.1093/intimm/8.5.641.
10
Identification of an HLA-A*0201-restricted cytotoxic T lymphocyte epitope from the lung carcinoma antigen, Lengsin.鉴定肺癌抗原 Lengsin 上的一个 HLA-A*0201 限制性细胞毒性 T 淋巴细胞表位。
Int J Oncol. 2011 Oct;39(4):1041-9. doi: 10.3892/ijo.2011.1089. Epub 2011 Jun 17.

引用本文的文献

1
Modern approaches to radiotherapy in primary cutaneous lymphomas: insights and recommendations from the DEGRO dermato-oncology working group.原发性皮肤淋巴瘤放射治疗的现代方法:DEGRO皮肤肿瘤学工作组的见解与建议
Strahlenther Onkol. 2025 Sep 9. doi: 10.1007/s00066-025-02453-5.
2
Efficacy and safety of radiotherapy combined with immunotherapy and targeted therapy versus immunotherapy plus targeted therapy alone in unresectable hepatocellular carcinoma: a retrospective study.放疗联合免疫治疗与靶向治疗对比单纯免疫治疗加靶向治疗用于不可切除肝细胞癌的疗效与安全性:一项回顾性研究
Front Oncol. 2025 Aug 20;15:1643304. doi: 10.3389/fonc.2025.1643304. eCollection 2025.
3

本文引用的文献

1
Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor.B16黑色素瘤肿瘤的局部放射治疗增加了肿瘤抗原特异性效应细胞的产生,这些细胞会迁移至肿瘤部位。
J Immunol. 2005 Jun 15;174(12):7516-23. doi: 10.4049/jimmunol.174.12.7516.
2
Induction of an antigen cascade by diversified subcutaneous/intratumoral vaccination is associated with antitumor responses.通过多样化的皮下/瘤内接种诱导抗原级联反应与抗肿瘤反应相关。
Clin Cancer Res. 2005 Mar 15;11(6):2416-26. doi: 10.1158/1078-0432.CCR-04-1380.
3
High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens.
Cancer Immunotherapy in Combination with Radiotherapy and/or Chemotherapy: Mechanisms and Clinical Therapy.
癌症免疫疗法与放疗和/或化疗联合应用:作用机制与临床治疗
MedComm (2020). 2025 Aug 31;6(9):e70346. doi: 10.1002/mco2.70346. eCollection 2025 Sep.
4
Synergies between radiotherapy and immunotherapy: a systematic review from mechanism to clinical application.放疗与免疫治疗之间的协同作用:从机制到临床应用的系统综述
Front Immunol. 2025 Aug 11;16:1554499. doi: 10.3389/fimmu.2025.1554499. eCollection 2025.
5
Roles of the phagocytosis checkpoint in radiotherapy.吞噬作用检查点在放射治疗中的作用。
Cell Death Dis. 2025 Aug 20;16(1):630. doi: 10.1038/s41419-025-07921-5.
6
Real-World Outcomes of Chemoradiotherapy in Patients with Stage II/III Non-Small-Cell Lung Cancer in the Durvalumab Era: An Observational Study.度伐利尤单抗时代II/III期非小细胞肺癌患者放化疗的真实世界结局:一项观察性研究
Cancers (Basel). 2025 Jul 29;17(15):2498. doi: 10.3390/cancers17152498.
7
Immunotherapy combined with radiotherapy for advanced non-small cell lung cancer: Current status and challenge (Review).免疫疗法联合放疗治疗晚期非小细胞肺癌:现状与挑战(综述)
Oncol Lett. 2025 Aug 4;30(4):469. doi: 10.3892/ol.2025.15215. eCollection 2025 Oct.
8
MicroRNAs in the abscopal effect: bridging radiotherapy and systemic anti-tumor immunity for enhanced cancer therapy.远隔效应中的微小RNA:连接放射治疗与全身抗肿瘤免疫以增强癌症治疗效果
Clin Exp Metastasis. 2025 Aug 13;42(5):48. doi: 10.1007/s10585-025-10364-z.
9
Tumor Evolution Driving Genome Instability, Immune Interactions, and Response to Radiotherapy.肿瘤进化驱动基因组不稳定、免疫相互作用及对放疗的反应。
Cancer J. 2025;31(4). doi: 10.1097/PPO.0000000000000777. Epub 2025 Aug 11.
10
Consolidative thoracic radiotherapy improves the prognosis of extensive stage small-cell lung cancer patients in the chemoimmunotherapy era: a multicenter retrospective analysis.巩固性胸部放疗改善化疗免疫治疗时代广泛期小细胞肺癌患者的预后:一项多中心回顾性分析
Ann Med. 2025 Dec;57(1):2542434. doi: 10.1080/07853890.2025.2542434. Epub 2025 Aug 4.
黑色素瘤患者接种肿瘤抗原前后血液中抗肿瘤T细胞的高频率。
J Exp Med. 2005 Jan 17;201(2):241-8. doi: 10.1084/jem.20041379.
4
Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes.对人类肿瘤细胞进行亚致死剂量照射可调节其表型,从而增强细胞毒性T淋巴细胞的杀伤作用。
Cancer Res. 2004 Nov 1;64(21):7985-94. doi: 10.1158/0008-5472.CAN-04-1525.
5
External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing.肿瘤的外照射放疗会改变肿瘤细胞的表型,使其易于被疫苗介导的T细胞杀伤。
Cancer Res. 2004 Jun 15;64(12):4328-37. doi: 10.1158/0008-5472.CAN-04-0073.
6
Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression.雷帕霉素靶蛋白(TOR):营养和生长因子信号的整合者以及细胞生长与细胞周期进程的协调者。
Oncogene. 2004 Apr 19;23(18):3151-71. doi: 10.1038/sj.onc.1207542.
7
A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation.TPPII在修剪蛋白酶体降解产物以进行MHC I类抗原呈递中起主要作用。
Immunity. 2004 Apr;20(4):495-506. doi: 10.1016/s1074-7613(04)00074-3.
8
Translation of the radioresistance kinase TLK1B is induced by gamma-irradiation through activation of mTOR and phosphorylation of 4E-BP1.辐射抗性激酶TLK1B的翻译是通过mTOR的激活和4E-BP1的磷酸化由γ射线诱导产生的。
BMC Mol Biol. 2004 Apr 7;5:1. doi: 10.1186/1471-2199-5-1.
9
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated.电离辐射对远处未治疗肿瘤的抑制作用(远隔效应)是由免疫介导的。
Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):862-70. doi: 10.1016/j.ijrobp.2003.09.012.
10
Identification of differentially expressed genes in mouse kidney after irradiation using microarray analysis.利用微阵列分析鉴定小鼠肾脏照射后差异表达的基因。
Radiat Res. 2004 Jan;161(1):28-38. doi: 10.1667/rr3097.